Breast screening: the facts--or maybe notP. C Gotzsche, Karsten Juhl Jørgensen, O. J. Hartling et al.|BMJ|2009Cited by 156
Informed choice requires information about both benefits and harmsKarsten Juhl Jørgensen, Peter C Gøtzsche, John Brodersen et al.|Journal of Medical Ethics|2009Cited by 54
Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenonThomas Gj�rup, Stig Lønberg Nielsen, O. J. Hartling et al.|European Journal of Clinical Pharmacology|1986Cited by 20
A cause for celebration, and cautionKarsten Juhl Jørgensen, Peter C Gøtzsche, O. J. Hartling et al.|BMJ|2009Cited by 6